These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 3410937)
21. Growth response relationship between growth hormone dose and short term growth in patients with Turner's syndrome. Ross JL; Long LM; Skerda M; Cassorla F; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1986 Oct; 63(4):1028-30. PubMed ID: 3745402 [TBL] [Abstract][Full Text] [Related]
22. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281 [TBL] [Abstract][Full Text] [Related]
23. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome. Mauras N; Rogol AD; Veldhuis JD J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569 [TBL] [Abstract][Full Text] [Related]
24. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome. Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937 [TBL] [Abstract][Full Text] [Related]
32. Growth hormone treatment in girls with Turner's syndrome. A review of the literature. Wilton P Acta Paediatr Scand; 1987 Mar; 76(2):193-200. PubMed ID: 3296625 [TBL] [Abstract][Full Text] [Related]
33. [Effect of hormonal treatment on bone mineralization in Turner syndrome]. Saggese G; Cinquanta L; Bertelloni S Arch Pediatr; 1998; 5 Suppl 4():371S-374S. PubMed ID: 9853086 [TBL] [Abstract][Full Text] [Related]
34. What is the value of growth hormone treatment in short children with specified syndrome? Turner's syndrome, osteochondrodysplasias, Prader-Willi syndrome, Noonan syndrome. Nilsson KO Acta Paediatr Scand Suppl; 1989; 362():61-8. PubMed ID: 2485602 [No Abstract] [Full Text] [Related]
35. A Critical Appraisal of Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome Patients in Turkey. Yavaş Abalı Z; Darendeliler F; Neyzi O J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):490-495. PubMed ID: 27354120 [TBL] [Abstract][Full Text] [Related]
38. Replacement therapy in hypothalamus-pituitary insufficiency: management in the adolescent. Stahnke N; Koehn H Horm Res; 1990; 33 Suppl 4():38-44. PubMed ID: 2174018 [TBL] [Abstract][Full Text] [Related]
39. Safety of high doses of recombinant human growth hormone. Van Loon K Horm Res; 1998; 49 Suppl 2():78-81. PubMed ID: 9730677 [TBL] [Abstract][Full Text] [Related]
40. Perspectives on growth promoting treatment for patients with Turner syndrome in Japan. Tanaka T Clin Pediatr Endocrinol; 2020; 29(3):91-97. PubMed ID: 32694884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]